![]() |
Volumn 280, Issue 3, 2001, Pages 861-867
|
Repression of cyclin B1 expression after treatment with adriamycin, but not cisplatin in human lung cancer A549 cells
a
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
COMPLEMENTARY DNA;
CYCLIN B1;
DOXORUBICIN;
ETOPOSIDE;
IRINOTECAN;
MESSENGER RNA;
PROTEIN P53;
ARTICLE;
CANCER CELL CULTURE;
CANCER CHEMOTHERAPY;
CELL CYCLE;
CELL DIFFERENTIATION;
CELL GROWTH;
CONTROLLED STUDY;
DNA DAMAGE;
DRUG EFFECT;
DRUG MECHANISM;
FLOW CYTOMETRY;
GENE EXPRESSION REGULATION;
HUMAN;
HUMAN CELL;
LUNG CANCER;
NUCLEOTIDE SEQUENCE;
PRIORITY JOURNAL;
PROTEIN PHOSPHORYLATION;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
|
EID: 0034815639
PISSN: 0006291X
EISSN: None
Source Type: Journal
DOI: 10.1006/bbrc.2000.4231 Document Type: Article |
Times cited : (41)
|
References (22)
|